RecruitingPHASE1, PHASE2NCT04729543

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

Studying Uveal melanoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Erasmus Medical Center
Intervention
Adoptive therapy with autologous MC2 TCR T cells(biological)
Enrollment
20 target
Eligibility
18 years · All sexes
Timeline
2020 – 2027

Study locations (1)

Collaborators

Ludwig Institute for Cancer Research · Dutch Cancer Society · Stichting Coolsingel Rotterdam grant · Jan Ivo Stichting grant

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04729543 on ClinicalTrials.gov

Other trials for Uveal melanoma

Additional recruiting or active studies for the same condition.

See all trials for Uveal melanoma →

← Back to all trials